Paychex, Inc.

The forensic scores present a mixed picture that is more nuanced than the headline numbers suggest. The Beneish M-Score is -2.304, which is below the -1.78 threshold and therefore not in the elevated manipulation-risk zone. This is a statistical screen built from balance sheet and income relationships, so it is a reassurance signal on that screen only, not a verdict on the filings. The Altman Z″-Score is 2.47, which falls in the grey zone between 1.10 and 2.60. That zone means the model neither clearly signals distress nor clearly signals safety, and given the jump in debt it is a reading worth tracking. The Piotroski F-Score is 4 of 8 computable signals, meaning four of the eight computable tests of profitability, leverage, and efficiency were met. Operating cash flow of $1.9 billion against net income of $1.66 billion gives a ratio of 1.15, so reported earnings are backed by cash in fiscal 2025, though operating cash flow was flat from fiscal 2024. The 10-K risk factors name specific exposures: generative AI and machine learning products that may contain undetected errors, software defects that could expose the company to liability, and cyberattacks on the cloud platforms it hosts for clients. The 10-Q states that disclosure controls were effective as of February 28, 2026, and that no internal control changes materially affected reporting that quarter. The credit facilities are the 2017 Credit Agreement, amended through Amendment No. 6 dated January 23, 2026, and the 2019 Credit Agreement, amended through Amendment No. 4 dated January 23, 2026, both with JPMorgan Chase Bank, N.A. as administrative agent. Readers may want to look at how those facilities relate to the $4.55 billion of long-term debt.

Catalyst.Paychex's fiscal 2025 results (year ended May 31, 2025) show revenue of $5.41 billion, up 5.4% from $5.13 billion in fiscal 2024. Operating income rose to $2.21 billion from $2.17 billion, about 1.8%, while net income eased to $1.66 billion from $1.69 billion. The 10-Q excerpt provided does not walk through revenue drivers, so the visible current activity is capital allocation. On January 16, 2026, the Board approved a new program to repurchase up to $1.0 billion of common stock with no expiration date, stated to manage dilution. In the January and February 2026 months, the company repurchased 0.8 million shares for $75.0 million, leaving $925.0 million of authorization.

Hidden risk.The most easily missed tension is the balance sheet. Total liabilities rose from $6.58 billion at May 31, 2024 to $12.44 billion at May 31, 2025, and long-term debt rose from $798.6 million to $4.55 billion, while equity grew only from $3.8 billion to $4.13 billion. The excerpts provided do not explain the cause of this jump, so readers may want to look at the debt notes and financing disclosures in the full 10-K. The risk factors also stress cyberattacks and data breaches involving bank account and social security numbers, plus failures of third-party providers such as banks that transfer client funds. Any disruption there would carry more weight with the larger liability base.